Stereotactic body radiotherapy shows favourable long-term outcomes and low severe toxicity in studies

Stereotactic body radiotherapy has shown good long-term outcomes and low rates of severe toxicity, making it a valid treatment option for men with low- and intermediate-risk prostate cancer, according to three studies recently presented at the 36th European Society for Radiotherapy and Oncology (ESTRO) Annual Meeting
Prostate Cancer News Today